Therapeutic strategy for multiple sclerosis targeting NK and NKT cells

Clinical Neurology

Volumn 41, Issue 12, 2001, Pages 1162-1164

  Yamamura, Takashi ^a  

^a NONE

Author keywords

Multiple sclerosis; NK cells; NKT cells; Regulatory cells; Therapeutic strategy

Indexed keywords

CD1 ANTIGEN; CYTOKINE; GLYCOLIPID; INTERLEUKIN 4; INTERLEUKIN 5; LIGAND;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; REMISSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; CYTOKINES; HUMANS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LIGANDS; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 0035760908     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Zhang BN, Yamamura T, Kondo T, et al: Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186: 1677-1687, 1997
2. Shi F, Ljunggren HG, Sarvetnick N: Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 22: 97-101, 2001
3. Peritt D, Robertson S, Gri G, et al: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161: 5821-5824, 1998
4. Takahashi K, Miyake S, Kondo T, et al: Natural killer type 2 (NK2) bias in remission of multiple sclerosis. J Clin Invest 107: R23-R29, 2001
5. Kojo S, Adachi Y, Keino H, et al: Dysfunction of T cell receptor AV24AJ18+. BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 44: 1127-1138, 2001
6. Wilson SB, Kent SC, Patton KT, et al: Extreme Th1 bias of invariant Valpha 24J alpha Q T cells in type 1 diabetes. Nature 391: 177-181, 1998
7. Illés Z, Kondo T, Newcombe J, et al: Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 164: 4375-4381, 2000
8. Pal E, Tabira T, Kawano T, et al: Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J Immunol 166: 662-668, 2001
9. Miyamoto K, Miyake S, Yamamura T: A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature 413: 531-534, 2001